ATE285233T1 - Injektionsformulierungen von avermectinen und milbemycinen auf basis von rizinusöl - Google Patents

Injektionsformulierungen von avermectinen und milbemycinen auf basis von rizinusöl

Info

Publication number
ATE285233T1
ATE285233T1 AT97916406T AT97916406T ATE285233T1 AT E285233 T1 ATE285233 T1 AT E285233T1 AT 97916406 T AT97916406 T AT 97916406T AT 97916406 T AT97916406 T AT 97916406T AT E285233 T1 ATE285233 T1 AT E285233T1
Authority
AT
Austria
Prior art keywords
avermectins
caster oil
injection formulations
pct
milbemycins
Prior art date
Application number
AT97916406T
Other languages
German (de)
English (en)
Inventor
Michael Grosse-Bley
Richard Kujanek
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7790774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE285233(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of ATE285233T1 publication Critical patent/ATE285233T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT97916406T 1996-04-09 1997-03-27 Injektionsformulierungen von avermectinen und milbemycinen auf basis von rizinusöl ATE285233T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19613972A DE19613972A1 (de) 1996-04-09 1996-04-09 Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
PCT/EP1997/001569 WO1997037653A1 (de) 1996-04-09 1997-03-27 Injektionsformulierungen von avermectinen und milbemycinen auf basis von rizinusöl

Publications (1)

Publication Number Publication Date
ATE285233T1 true ATE285233T1 (de) 2005-01-15

Family

ID=7790774

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97916406T ATE285233T1 (de) 1996-04-09 1997-03-27 Injektionsformulierungen von avermectinen und milbemycinen auf basis von rizinusöl

Country Status (13)

Country Link
US (1) US6063394A (cg-RX-API-DMAC10.html)
EP (1) EP0896534B1 (cg-RX-API-DMAC10.html)
JP (1) JP4257870B2 (cg-RX-API-DMAC10.html)
CN (1) CN1095662C (cg-RX-API-DMAC10.html)
AT (1) ATE285233T1 (cg-RX-API-DMAC10.html)
AU (1) AU718807B2 (cg-RX-API-DMAC10.html)
BR (1) BR9708540B1 (cg-RX-API-DMAC10.html)
CA (1) CA2251087C (cg-RX-API-DMAC10.html)
DE (2) DE19613972A1 (cg-RX-API-DMAC10.html)
ES (1) ES2235230T3 (cg-RX-API-DMAC10.html)
NZ (1) NZ332224A (cg-RX-API-DMAC10.html)
PT (1) PT896534E (cg-RX-API-DMAC10.html)
WO (1) WO1997037653A1 (cg-RX-API-DMAC10.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
RS49838B (sr) * 1997-12-03 2008-08-07 Merck& Co. Inc., Injektibilne formulacije dugog dejstva koje sadrže hidrogenisano ricinusovo ulje
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
GB9827727D0 (en) 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
AU781682B2 (en) * 2000-03-20 2005-06-09 Zoetis Services Llc Sustained-release compositions for parenteral administration
US20050009762A1 (en) * 2003-06-06 2005-01-13 Strobel Michael Albert Application of water and organic solvent soluble ivermectin for topical and oral use
CN1275589C (zh) * 2002-05-31 2006-09-20 王玉万 含抗寄生虫药物的缓释注射剂
US7262214B2 (en) 2003-02-26 2007-08-28 Merial Limited 1-N-arylpyrazole derivatives in prevention of arthropod-borne and mosquito-borne diseases
US20050271459A1 (en) * 2004-06-03 2005-12-08 World Wide Stationery Mfg. Co., Ltd. Interlocking ring tip formations for paired ring members of a ring binder mechanism
NZ534939A (en) * 2004-08-26 2007-04-27 Bomac Research Ltd Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
DE102004053964A1 (de) * 2004-11-09 2006-05-11 Bayer Healthcare Ag Mittel gegen Demodikose
KR20100047311A (ko) * 2007-08-31 2010-05-07 아르키메데스 디벨로프먼트 리미티드 비-수성 약학 조성물
US20100022469A1 (en) * 2008-06-24 2010-01-28 Majid Razzak Anthelminthic formulations
CN102316876B (zh) 2009-02-16 2013-07-17 佐蒂斯有限责任公司 高剂量多拉菌素制剂
CN101773467B (zh) * 2010-01-20 2015-09-09 北京大北农动物保健科技有限责任公司 一种美贝霉素或美贝霉素肟的兽用缓释注射液及制备方法
KR101805087B1 (ko) * 2010-09-16 2017-12-05 주식회사 엘지화학 높은 방부력을 제공하는 오일 주사 제형
WO2013137748A1 (en) * 2012-03-13 2013-09-19 Bayer New Zealand Limited Long acting compositions
US20170232024A1 (en) 2014-08-04 2017-08-17 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
AU2018385766B2 (en) 2017-12-15 2022-12-01 Tarsus Pharmaceuticals, Inc. Isoxazoline parasiticide formulations and methods for treating blepharitis
BR112021016196A2 (pt) * 2019-03-01 2021-10-05 Boehringer Ingelheim Animal Health USA Inc. Composições injetáveis de clorsulon, métodos e usos das mesmas
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
US11638714B2 (en) 2020-11-10 2023-05-02 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes
US11077134B1 (en) 2020-11-10 2021-08-03 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes
CA3249951A1 (en) * 2022-01-28 2023-08-03 Rebel Medicine Inc Injectable pharmaceutical compositions for treating pain
CN114642632A (zh) * 2022-02-25 2022-06-21 河北科技大学 一种莫西克汀注射液及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914624A (cg-RX-API-DMAC10.html) * 1972-06-08 1974-02-08
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
OA06863A (fr) * 1980-08-04 1983-02-28 Merck & Co Inc Solubilisation de l'invermectine dans l'eau.
NZ210505A (en) * 1983-12-22 1988-06-30 Merck & Co Inc Parasiticidal compositions containing avermectin or milbemycin derivatives
DE3727648A1 (de) * 1987-08-19 1989-03-02 Bayer Ag Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung
US5510117A (en) * 1989-03-09 1996-04-23 Micro-Pak, Inc. Entrapment vehicle and method
DK0393890T3 (da) * 1989-04-11 1992-09-28 Pfizer Injicerbart præparat indeholdende 25-cyclohexyl-avermectin B1
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
EP0525307B1 (en) * 1991-07-23 1996-03-06 American Cyanamid Company Stable compositions for parenteral administration and their use
ES2131515T3 (es) * 1991-09-30 1999-08-01 Merck & Co Inc Formulados inyectables de accion prolongada que contienen aceite de ricino hidrogenado.
WO1994008566A1 (en) * 1992-10-21 1994-04-28 Micro Vesicular Systems, Inc. Entrapment vehicle and method

Also Published As

Publication number Publication date
PT896534E (pt) 2005-04-29
BR9708540B1 (pt) 2010-07-27
DE59712134D1 (de) 2005-01-27
WO1997037653A1 (de) 1997-10-16
US6063394A (en) 2000-05-16
AU718807B2 (en) 2000-04-20
AU2506697A (en) 1997-10-29
CN1215331A (zh) 1999-04-28
JP4257870B2 (ja) 2009-04-22
JP2000508301A (ja) 2000-07-04
CA2251087C (en) 2008-01-15
CA2251087A1 (en) 1997-10-16
DE19613972A1 (de) 1997-10-16
EP0896534B1 (de) 2004-12-22
ES2235230T3 (es) 2005-07-01
NZ332224A (en) 2000-06-23
CN1095662C (zh) 2002-12-11
HK1019404A1 (en) 2000-02-11
EP0896534A1 (de) 1999-02-17
BR9708540A (pt) 1999-08-03

Similar Documents

Publication Publication Date Title
ATE285233T1 (de) Injektionsformulierungen von avermectinen und milbemycinen auf basis von rizinusöl
IL137093A0 (en) Methods of inactivating bacteria including bacterial spores
DE69928952D1 (de) Chinolin-derivate und ihre verwendung als antibakterielle wirkstoffe
DE59710893D1 (de) Kosmetische oder pharmazeutische zubereitungen mit vermindertem klebrigkeitsgefühl
ATE283067T1 (de) Detoxifizierte mutanten bakterieller adp- ribosylierender toxine als parenterale adjuvantien
DE59706898D1 (de) Feste geschäumte wirkstoffzubereitungen
GR3035730T3 (en) Inhibitors of dipeptidyl-aminopeptidase type iv.
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
PT937074E (pt) Benzonaftiridinas como terapeutica bronquica
BG102616A (en) Substituted aza- and diazacycloheptane and cyclooctane derivatives and their application
ATE228845T1 (de) Injektionsformulierungen von avermectinen und milbemycinen
ES2175356T3 (es) Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4 fluorofenil)et il[-4- piperidinmetanol en el tratamiento de trastornos depresivos y trastornos bipolares.
ATE251457T1 (de) Substituierte 1,2,3,4-tetrahydro-2- dibenzofuranamine und 2- aminocyclohepta(b)benzofurane
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ATE215084T1 (de) Imidazopyridin-azolidinone
AU1545401A (en) Targeted marketing system with third party confidential database
ATE252102T1 (de) 9,10-diazatryclo(4.2.11 2,5)decan- und 9,10- diazatricyclo(3.3.1.1 2,6)decanderive mit analgetischer wirkung
DE59712297D1 (de) 3-alkylimidazopyridine
GB9607119D0 (en) Compounds
ATE194079T1 (de) Verwendung von einer suspension auf der basis von sucralfatgel als antazidum
ES2141923T3 (es) Uso hipocolesterolemico, antiaterosclerotico e hipotrigliceridemico de derivados aminoacetilmercapto.
AU2687401A (en) Use of wood waste or extracts as insecticide
DE59904009D1 (de) Desinfektionsmittel und Antiseptikum auf der Basis von Alkoholen
CA2096345A1 (en) Avermectins and milbemycins to treat parasitic in dogs
PT958290E (pt) Derivados de 1,4-di-hidropiridina e seu uso em terapia